Assessment of immune response to SARS-CoV-2 withfully automated MAGLUMI 2019-nCoV IgG and IgM chemiluminescence immunoassays
Detection Principle
ImmunoAssay-Antibody
Target
IgG, IgM
Testing Method Category
Other Immuno assay
Testing Method
MAGLUMI 2019-nCoV
Testing Method - Additional Info
compared with results from Anti-SARS-CoV-2 IgA and IgG enzyme-linked immunosorbent assays (ELISAs; Euroimmun AG, Luebeck, Germany)
Reported Performance
Remarks: overall concordance of each test is 90%, more detailed info in the text
Sample Size
131 patients
Peer-reviewed
yes
The database contains available information from scientific literature that is being updated periodically. Please note that the provided information (as retrieved from analysed papers) is provided only for devices commercially available with CE-IVD mark. Acknowledgements